11-12 Flashcards

1
Q

Metabolic acidosis is pH< ____
Reduced ____
____ compensation by ___

A

7.36
HCO3
Respiratory, by hyperventilating resulting in reduced PCO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In metabolic acidosis, an anion gap develops when the accumulating acid contains ___

A

An anion other than Cl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The most common cause of increased anion gap is ____.

What is a normal anion gap?

A

Metabolic acidosis

12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most of the unmeasured anion is ___.

A

Albumin (normal anion gap is 3x the albumin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anion gap calculation:

A

Na-(Cl+HCO3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of anion gap acidosis:

A
L-Lactic acidosis
Uremia
D-Lactic acidosis
Alcoholic and diabetic ketoacidosis 
Toluene
Ethylene glycol and methanol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If the anion gap is >30, the most common anions are ____

A

Lactate (lactic acidosis) and B-hydroxybutyrate and acetoacetate (ketoacidosis) of

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metformin can cause ___

A

Type B/D-Lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you distinguish between extrarenal and renal causes of metabolic acidosis?

A

Urinary anion gap = U.Na + U.K - U.Cl
Normally 30-50
-negative value suggests increased renal excretion of unmeasured cation such as NH4
-positive for renal origin, NH4 excretion is minimal
-large negative is extrarenal, increased NH4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type 1 RTA
Type 2 RTA
Type 4 RTA

A
  1. Classical distal, low plasma K, high Urine pH,
  2. Proximal, low plasma K, low Urine pH
  3. Generalized distal defect, high plasma K, low or high Urine pH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mineral acid-induced acidosis ____ K.

Organic acid-induced acidosis ____ K.

A

Increases

Does not change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metabolic alkalosis is serum bicarbonate ___

A

Greater than 28 (total CO2 greater than 30)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Metabolic alkalosis ___ respiration

A

Inhibits

*do not extubate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PCO2 increases by ____ for each 1 mmol/L increase in HCO3

A

0.7 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

____ is due to defective Na-K-2Cl cotransporter. It presents as hypokalemic, hypochloremic metabolic alkalosis

A

Bartters syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

____ is due to defected channels and is characterized by severe hypomagnesemia and hypocalcemia and predominantly neuromuscular symptoms such as cramping or tetany

A

Gitelmans syndrome

17
Q

____ is due to increased activity of a collecting duct Na channel, and presents as HTN due to volume expansion, hypokalemic acidosis, and normal aldosterone levels

A

Liddles syndrome

18
Q
Chloride resistant alkalosis 
Treatment for 
1. Liddles syndrome
2. Bartters syndrome
3. Gitelmans syndrome
A
  1. Amiloride
  2. NSAIDs
  3. NSAIDs and Ca and Mg replacement
19
Q

USPSTF recommendations:

Grade A

A

Strongly recommended

Good evidence that benefits substantially outweigh harms

20
Q

USPSTF recommendations:

Grade B

A

Recommended

Fair evidence that benefits outweigh harms

21
Q

USPSTF recommendations:

Grade C

A

No recommendation for or against

Fair evidence, but balance of benefits and harms is too close

22
Q

USPSTF recommendations:

Grade D

A

Recommends against routinely providing

Fair evidence that it is ineffective or harms outweigh benefits

23
Q

USPSTF recommendations:

Grade I

A

Insufficient evidence

24
Q

Three criteria are important when deciding what conditions to screen for:

A
  1. Burden of suffering (consider prevalence and severity)
  2. Effectiveness, safety, and cost
  3. Performance of test
25
Q

Screening for tobacco?

A

Screen ALL

26
Q

Screening for AAA?

A

Men 65-75 who have ever smoked should be screened once with US (grade B)
*recommends against screening women who have never smoked

27
Q

Screening for Carotid A. Stenosis?

A

Recommends against in asymptomatic (grade D)

28
Q

Screening for Diabetes?

A

40-70 years who are overweight or obese

29
Q

Criteria for Diabetes dx?

A
  1. HbA1c 6.5 or higher
  2. Fasting plasma glucose 126 or higher
  3. 2 hour plasma glucose of 200 or higher during 75g oral glucose tolerance test
  4. Random plasma glucose 200 or higher with classic symptoms of hyperglycemia
30
Q

Screening for lung cancer?

A

Annual with low dose CT
55-80 years
30 pack year smoking hx who currently smoke or have quit within 15 years

31
Q

Screening for breast cancer?

Normal risk or low risk?

A
  • Mammo every 2 years for women 50-74
  • Women with family hx of breast, ovarian, tubal, or peritoneal cancer
  • yearly after 45
32
Q

Screening for breast cancer?

High risk

A

MRI and mammo every year

33
Q

Screening for cervical cancer?

A

21-65 every 3 years
30-65 every 5 years
*Against screening women >65 or those who have had a hysterectomy with cervix removal

34
Q

Screening for colon cancer?

A

50-75 years (grade A)

>85 not recommended

35
Q

Screening for colon cancer?

1. Tests that find polyps and cancer

A

Flexible sigmoidoscopy every 5 years
Colonoscopy every 10 years
Double contrast barium enema every 5 years
CT colonography every 5 years

36
Q

Screening for colon cancer?

2. Tests that find primarily cancer

A

Annual gFOBT
Annual iFOBT/FIT
Stool DNA test, interval uncertain